Nov 27, 2017 by Corporate

a. Subjects 6-12 years of age with persistent asthma for at least 12 months
b. At least 3 months of therapy on medium-dose inhaled corticosteroids plus a second asthma controller or high-dose inhaled corticosteroids alone
c. One or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids